InvestorsHub Logo
Followers 1
Posts 234
Boards Moderated 0
Alias Born 10/03/2014

Re: Polyphemus post# 32

Tuesday, 10/22/2019 9:07:42 AM

Tuesday, October 22, 2019 9:07:42 AM

Post# of 1032
Why would we expect sales to increase geometrically as they cut back on sales force and promotion to lower the burn rate? The growth we see comes from increased usage by a prescribing base of 2,000 docs.

While I expect steep growth and getting to a $10million run rate 3rd quarter 2020, I am concerned about physicians that have tried but are not continuing to prescribe. Very hard to get a physician to try, but they seem to retain only about 85% as continuing to prescribe. Hope to see some better numbers, or at least an explanation in the quarterly report. Maybe it all relates to the reimbursement issue that they are working on.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ECOR News